Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
36.15
+0.08 (0.22%)
May 23, 2025, 3:00 PM CST
SHA:600211 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 1,008 | 1,051 | 800.91 | 369.84 | 208.94 | 418.1 | Upgrade
|
Depreciation & Amortization | 75.1 | 75.1 | 68.05 | 69.24 | 81.45 | 77.63 | Upgrade
|
Other Amortization | 0.74 | 0.74 | 1.01 | 1.55 | 0.68 | 0.32 | Upgrade
|
Loss (Gain) From Sale of Assets | -1.9 | -1.9 | -0.34 | 0.23 | 0.04 | 0 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | 190.38 | 218.62 | 458.19 | 0.03 | Upgrade
|
Loss (Gain) From Sale of Investments | 3.88 | 3.88 | 170.09 | 7.14 | -146.47 | -0.98 | Upgrade
|
Provision & Write-off of Bad Debts | 0.6 | 0.6 | 0.04 | -0.51 | -1.39 | 0.39 | Upgrade
|
Other Operating Activities | -95.36 | -12.63 | -5.68 | 81.94 | 15.93 | 3.87 | Upgrade
|
Change in Accounts Receivable | 98.83 | 98.83 | -237.89 | 22.82 | -317.1 | -21.7 | Upgrade
|
Change in Inventory | -22.56 | -22.56 | -16.56 | -18.87 | -67.2 | 3.32 | Upgrade
|
Change in Accounts Payable | -163.73 | -163.73 | 147.4 | 38.73 | 164.85 | 28.01 | Upgrade
|
Change in Other Net Operating Assets | 2.02 | 2.02 | 1.87 | 52.43 | -1.62 | -78.25 | Upgrade
|
Operating Cash Flow | 868.42 | 994.79 | 1,063 | 837.38 | 366.53 | 428.17 | Upgrade
|
Operating Cash Flow Growth | -22.18% | -6.45% | 26.99% | 128.46% | -14.39% | -12.55% | Upgrade
|
Capital Expenditures | -40.9 | -37.6 | -21.69 | -101.96 | -425.58 | -221.29 | Upgrade
|
Sale of Property, Plant & Equipment | 2.78 | 2.78 | 0.54 | 0.11 | 16.78 | 0.01 | Upgrade
|
Investment in Securities | 410 | 367.91 | -829.46 | -471.69 | -334.97 | 280 | Upgrade
|
Other Investing Activities | 23.59 | 21.39 | 18.72 | 12.3 | 2.97 | 10.44 | Upgrade
|
Investing Cash Flow | 395.49 | 354.49 | -831.88 | -561.25 | -740.8 | 69.16 | Upgrade
|
Short-Term Debt Issued | - | 533.5 | 699.51 | 485.73 | - | - | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 576.54 | 10.4 | Upgrade
|
Total Debt Issued | 515.9 | 533.5 | 699.51 | 485.73 | 576.54 | 10.4 | Upgrade
|
Short-Term Debt Repaid | - | -760.97 | -685.73 | -534.27 | - | - | Upgrade
|
Long-Term Debt Repaid | - | -0.93 | -1.65 | -3.56 | -56.08 | - | Upgrade
|
Total Debt Repaid | -761.9 | -761.9 | -687.39 | -537.82 | -56.08 | - | Upgrade
|
Net Debt Issued (Repaid) | -246 | -228.4 | 12.13 | -52.09 | 520.46 | 10.4 | Upgrade
|
Common Dividends Paid | -577.65 | -494.41 | -494.47 | -98.18 | -132.49 | -188.83 | Upgrade
|
Other Financing Activities | -10.18 | -10.18 | -1.34 | 4.9 | -11.3 | - | Upgrade
|
Financing Cash Flow | -833.83 | -732.99 | -483.69 | -145.37 | 376.67 | -178.43 | Upgrade
|
Foreign Exchange Rate Adjustments | 4.03 | 7.44 | 7.04 | 40.11 | -14.42 | -27.87 | Upgrade
|
Net Cash Flow | 434.11 | 623.72 | -245.11 | 170.87 | -12.02 | 291.03 | Upgrade
|
Free Cash Flow | 827.53 | 957.19 | 1,042 | 735.41 | -59.05 | 206.87 | Upgrade
|
Free Cash Flow Growth | -24.64% | -8.12% | 41.65% | - | - | -53.05% | Upgrade
|
Free Cash Flow Margin | 29.40% | 34.10% | 33.24% | 28.79% | -2.76% | 15.07% | Upgrade
|
Free Cash Flow Per Share | 2.57 | 2.97 | 3.23 | 2.28 | -0.18 | 0.64 | Upgrade
|
Cash Interest Paid | 9.64 | 9.64 | - | - | - | - | Upgrade
|
Cash Income Tax Paid | 500.59 | 500.59 | 443.23 | 272.41 | 274.84 | 185.36 | Upgrade
|
Levered Free Cash Flow | 380.27 | 483.26 | 585.86 | 456.08 | -60.38 | 76.87 | Upgrade
|
Unlevered Free Cash Flow | 386.2 | 489.19 | 593.11 | 465.06 | -57.68 | 77.53 | Upgrade
|
Change in Net Working Capital | 167.53 | 107.45 | 103.44 | -66.06 | 72.2 | 33.71 | Upgrade
|
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.